Cargando…

P1211: CLINICAL HETEROGENEITY OF HIGH-GRADE B-CELL LYMPHOMA. EDGE OF TRANSFORMATION.

Detalles Bibliográficos
Autores principales:	Misyurina, A., Kravchenko, S., Magomedova, A., Kovrigina, A., Obukhova, T., Sychevskaya, K., Zakharko, E., Rubkina, E., Misyurin, V., Babaeva, F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429292/ http://dx.doi.org/10.1097/01.HS9.0000847708.51426.88

Ejemplares similares

PB2130: RATIONAL FOR METHOTREXATE USAGE FOR THE TREATMENT AND PREVENTION OF CNS INVOLVEMENT IN PATIENTS WITH HIGH-GRADE B-CELL LYMPHOMAS.
por: Misyurina, A., et al.
Publicado: (2022)

PB2089: ALGORITHM FOR SEVERE COVID-19 RISK STRATIFICATION DEPENDING MONOCLONAL ANTI-CD20 ANTIBODIES TREATMENT DURATION IN NON-HODGKIN LYMPHOMA PATIENTS.
por: Sychevskaya, K., et al.
Publicado: (2022)

PB2282: HERPESVIRUSES REPLICATION DURING COVID-19 IN NON-HODGKIN’S LYMPHOMA PATIENTS.
por: Sychevskaya, K., et al.
Publicado: (2022)

P1207: MULTICENTER RANDOMIZED CONTROLLED (COMPARATIVE) OPEN PROSPECTIVE STUDY TO EVALUATE THE EFFICACY OF THE R-DA-EPOCH-21 AND R-MNHL-BFM-90 ± AUTO- HSCT PROGRAMS IN PATIENTS WITH DE NOVO DIFFUSE B-CELL LAR
por: Magomedova, A., et al.
Publicado: (2022)

PB2154: TP53 GENE MUTATION DIVERSITY IN RUSSIAN PATIENTS WITH B-CELL LYMPHOMAS
por: Biderman, B., et al.
Publicado: (2022)

P1211: TUMOR-ACTIVATED LYMPH NODE FIBROBLASTS SUPPRESS T CELL FUNCTION IN DIFFUSE LARGE B CELL LYMPHOMA
por: Apollonio, Benedetta, et al.
Publicado: (2023)

P1301: HIGH-DOSE THERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION AS THE FIRST-LINE THERAPY OF FOLLICULAR LYMPHOMA: RESULTS FROM A PROSPECTIVE SINGLE-CENTER STUDY.
por: Gabeeva, Nelli, et al.
Publicado: (2023)

P1063: A SINGLE CENTER EXPERIENCE OF DIAGNOSTICS AND TREATMENT OF RARE MYELOID/LYMPHOID NEOPLASMS WITH PDGFRB GENE REARRANGEMENT
por: Nemchenko, Irina, et al.
Publicado: (2023)

P1306: CLINICAL AND GENOMIC ANALYSIS OF HIGH-GRADE TRANSFORMATION OF MARGINAL ZONE LYMPHOMA
por: Yannakou, C., et al.
Publicado: (2022)

Correction to Lancet Oncol 2019; 20: 1211–25
Publicado: (2019)

Correction to Lancet Oncol 2019; 20: 1211–25
Publicado: (2021)

P965: FOLLOW-UP ANALYSIS OF THE RANDOMIZED PHASE II TRIAL OF BORTEZOMIB, LENALIDOMIDE, DEXAMTHASONE WITH/WITHOUT ELOTUZUMAB FOR NEWLY DIAGNOSED, HIGH RISK MULTIPLE MYELOMA (SWOG-1211)
por: Usmani, S., et al.
Publicado: (2022)

1211. Response to Fecal Microbiota Transplant (FMT) in Refractory Clostridioides difficile Infection (CDI) is Modest Compared to Recurrent CDI in Hospitalized Patients
por: Shin, Jae Hyun, et al.
Publicado: (2020)

P1260: UNRAVELING THE GENETICS OF TRANSFORMED SPLENIC MARGINAL ZONE LYMPHOMA
por: Grau, M., et al.
Publicado: (2022)

X-ray spectrum and variability of the quasar PG1211+143
por: Yaqoob, T, et al.
Publicado: (1994)

1211. Incidence of All-Cause Community-Acquired Pneumonia in Ontario and British Columbia, Canada, 2002-2018; a Canadian Immunization Research Network (CIRN) study
por: Nasreen, Sharifa, et al.
Publicado: (2021)

The arrhythmogenic cardiomyopathy phenotype associated with PKP2 c.1211dup variant
por: Bos, Thomas A., et al.
Publicado: (2023)

Oestrogen receptor negative-progesterone receptor positive phenotype in 1,211 breast tumours.
por: Pichon, M. F., et al.
Publicado: (1992)

Association between Occupation and Cervical Disc Degeneration in 1211 Asymptomatic Subjects
por: Machino, Masaaki, et al.
Publicado: (2022)

P1043: EFFICACY AND SAFETY OF TRAMETINIB IN ADULTS WITH LANGERHANS CELL HISTIOCYTOSIS AND ERDHEIM-CHESTER DISEASE
por: Latyshev, Vitalii, et al.
Publicado: (2023)

1211. Assessing the Applicability of Enhanced Barrier Precautions among Adult Hospitalized Patients
por: Makhija, Jinal, et al.
Publicado: (2022)

Gastro-intestinal bleeding in 1211 ventilated trauma patients: a multivariate analysis of the risk factors
por: Petit, L, et al.
Publicado: (1999)

Texting while driving: A study of 1211 U.S. adults with the Distracted Driving Survey
por: Gliklich, Emily, et al.
Publicado: (2016)

Analysis of Uncharacterized mKiaa1211 Expression during Mouse Development and Cardiovascular Morphogenesis
por: L. Snider, Paige, et al.
Publicado: (2019)

KIAA1211 plays an oncogenic role in human non-small cell lung cancer
por: Liu, Zhengcheng, et al.
Publicado: (2019)

P1270: IMMUNE REGULATORY CELLS IN B-CELL LYMPHOMAS: SIGNIFICANT HETEROGENEITY ACROSS HISTOLOGIC TYPES.
por: STAVROULAKI, M., et al.
Publicado: (2022)

P1164: IMAGE-BASED DETECTION OF HIGH-GRADE B CELL LYMPHOMAS (DH-L)
por: Avivi, I., et al.
Publicado: (2022)

P912: COVID19 SEVERITY AND THERAPEUTIC OPTIONS IN PATIENTS WITH MULTIPLE MYELOMA
por: Karimova, E., et al.
Publicado: (2022)

P1586: IN-HOSPITAL MORTALITY AND POOR PROGNOSIS FACTORS ASSESSMENT IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND COVID-19.
por: Ivanova, D., et al.
Publicado: (2022)

P1612: ACUTE MYELOID LEUKEMIA IN ADULT PATIENTS: FEATURES OF TREATMENT IN CONTEXT OF THE COVID-19 PANDEMIC.
por: Tolstykh, T., et al.
Publicado: (2022)

Prognostic impact of tumor mutation burden and the mutation in KIAA1211 in small cell lung cancer
por: Zhou, Mengting, et al.
Publicado: (2019)

Molecular characterization of heterogeneity in adult T-cell leukaemia/lymphoma
por: Kagdi, Huseini, et al.
Publicado: (2015)

Molecular characterization of heterogeneity in adult T-cell leukaemia/lymphoma
por: Kagdi, Huseini, et al.
Publicado: (2015)

Laboratoire européen de physique des particules division ps groupe lp CH-1211 Genève 23 SUISSE
por: ROUMY A.
Publicado: (1995)

Progression and Transformation of Clonally Heterogeneous B-cell Lymphoma
por: Weiss, Robert F., et al.
Publicado: (2015)

Left ventricular remodeling following percutaneous edge-to-edge repair using Mitraclip
por: Paelinck, Bernard P, et al.
Publicado: (2015)

P1574: ANTINEOPLASTIC THERAPY FOR HEMATOLOGIC MALIGNANCIES DURING COVID-19
por: Chudnova, T., et al.
Publicado: (2022)

Effects of high doses of selenium on the antioxidant status after liver resection
por: Obukhova, O, et al.
Publicado: (2011)

P1599: THERAPY AND HOSPITAL MORTALITY PREDICTORS IN PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS AND CONCOMITANT COVID-19 INFECTION
por: Polyakov, Y., et al.
Publicado: (2022)

Buffer therapy in metabolic acidosis after surgery-associated hemorrhage in pediatric oncology
por: Matinyan, N, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_n3ts9nec111j2dfe3fll6oho9d